Your shopping cart is empty

Subscriber login

Advanced Search

Home
Books
Conferences
DVDs
Newsletters
Form 483s
Pharma Quality Advisor
Webinar Training Pass
White Papers
Advertising/Sponsorships
About Us

Check out our free and informative ezines and sign up now

Home > Newsletters > Generic Line > Senators Urge FDA to Allow Changes to Drug Labels, Ending Sameness

Generic Line

May 23, 2012 | Vol. 29 No. 11

Senators Urge FDA to Allow Changes to Drug Labels, Ending Sameness

Three Senators are urging the FDA to end generic labeling preemption and allow generic-drug makers to make warning label changes even if it will no longer mirror the brand-drug label.

This article is viewable by subscribers only. To view this article, please select an option below.

Subscribe
Print This Page
RSS
Free Trial
Archives
Sample PDF

Bill Requiring Generic Opioid Makers to Mimic Abuse-Deterrent Features Reintroduced in House Legislators Press FDA on Safety of Opioid Generics Members of Congress Press FDA on Safety of Non-Tamper Resistant Opioid Generics Drug-Shortage Bill Aims to Make Generic Injectables More Profitable

Home
Advertising/Sponsorships
About Us
Contact Us
Site Map
Privacy Policy

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA.
Phone (703) 538-7600 - Fax (703) 538-7676 - Toll free (888) 838-5578.